Gateway Analytical Relocates to New Facility and Expands Capabilities

August 29, 2016

Facility Opens New Doors for Foreign Particulate Analysis and Identification Needs of the Global Pharmaceutical, Medical Device and Materials Industries.

Pittsburgh, PA (August 29, 2016) – Gateway Analytical, one of the world’s most trusted particle identification and characterization laboratories, is relocating to a larger headquarters facility to better serve the needs of its growing global customer base. The move is effective on September 1, 2016.

Gateway Analytical’s relocation is part of the company’s overall strategy of expanding its particulate characterization capabilities, enhancing current services and providing the highest levels of customer service. The new location in Gibsonia, Pennsylvania, near Pittsburgh, will house approximately 17,000 square feet (1,580 square meters) of laboratory and office space.

David Exline, founder and president of Gateway Analytical, says the move is a significant milestone for the company. “As Gateway Analytical continues to grow, the new laboratory and office space will cultivate greater innovation in the areas of particulate analysis and particulate characterization. Operating in the new, larger facility will further build on our foundation of providing fast, accurate and reliable results to customers across the globe.”

Dr. Jeffrey Cohen, president and CEO of parent company ChemImage Corporation, says the new facility will allow Gateway Analytical to deliver on its mission. “The need for effective particulate analysis and characterization, especially in the pharmaceutical, materials and medical device industries, has never been greater. Gateway Analytical’s new facilities will improve our ability to efficiently serve these industries.  Our goal is help our clients make our world healthier and safer, one particle at a time.”

Gateway Analytical’s laboratory area is specifically designed and dedicated to accommodate foreign particulate identification and characterization, featuring a HEPA filtered environment, separate clean rooms and a new, dedicated area for handling cytotoxic materials.